Saturday, September 5, 2026
Home Authors Posts by Ogkologos

Ogkologos

4329 POSTS 0 COMMENTS

A Meaningful Benefit of the Quadruplet-Based Isatuximab Plus VRd Regimen in...

Ogkologos -
0

Lorlatinib Slows Growth of ALK-Positive Lung Cancers, May Prevent Brain Metastases

Ogkologos -
0

EMA Recommends Granting a Marketing Authorisation for Erdafitinib

Ogkologos -
0

Trial Establishes Preferred Treatment for Some People with Esophageal Cancer

Ogkologos -
0

Adjuvant Dabrafenib Plus Trametinib Associated with Better RFS and DMFS than...

Ogkologos -
0

FDA Grants Accelerated Approval to Repotrectinib for Adult and Paediatric Patients...

Ogkologos -
0

Amivantamab Plus Lazertinib Shows Superior Efficacy to Osimertinib in First-Line Treatment...

Ogkologos -
0

Treatment with Brigatinib Results in Radiographic Responses and Clinical Benefit in...

Ogkologos -
0

Program Helps Medically Underserved, Minority Cancer Survivors Be More Active

Ogkologos -
0

Belantamab Mafodotin–Containing Triplets Confer a Significant PFS Benefit Among Previously Treated...

Ogkologos -
0
1...707172...433Page 71 of 433

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com